Your search returned 4 results.

Sort
Results
1.
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27692565
Year: 2017
Citation:
  • Clinical Breast Cancer. 17(1):76-78, 2017 Feb
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Gao JJ, Pohlmann PR, Swain SM, Tan M
2.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
  • Swain, Sandra M
PMID:
  • 28398846
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
3.
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
  • McCarron, Edward C
  • Swain, Sandra M
PMID:
  • 28954297
Year: 2018
Citation:
  • Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
  • MedStar Franklin Square Medical Center
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
4.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27693116
Year: 2017
Citation:
  • Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
Pages

Powered by Koha